U.S. markets open in 1 hour 24 minutes

CASI Pharmaceuticals, Inc. (CASI)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.8800-0.1500 (-7.39%)
At close: 4:00PM EDT

1.9000 +0.02 (1.06%)
Pre-Market: 8:00AM EDT

Show:
Income Statement
Balance Sheet
Cash Flow
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Breakdown
ttm
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Total Revenue
15,141
15,141
4,131
0
0
Cost of Revenue
9,508
9,508
3,935
-
-
Gross Profit
5,633
5,633
196
-
-
Operating Expense
38,946
38,946
40,187
26,504
10,751
Operating Income
-33,313
-33,313
-39,991
-26,504
-10,751
Net Non Operating Interest Income Expense
866
866
1,062
39.988
1.009
Other Income Expense
-15,064
-15,064
-6,433
-1,007
-19.891
Pretax Income
-47,511
-47,511
-45,362
-27,472
-10,770
Net Income Common Stockholders
-48,287
-48,287
-46,032
-27,472
-10,770
Diluted NI Available to Com Stockholders
-48,287
-48,287
-46,032
-27,472
-10,770
Basic EPS
-
-
-0.48
-0.32
-0.18
Diluted EPS
-
-
-0.48
-0.32
-0.18
Basic Average Shares
-
-
95,948
84,752
61,514
Diluted Average Shares
-
-
95,948
84,752
61,514
Total Operating Income as Reported
-51,526
-51,526
-46,958
-
-
Total Expenses
48,454
48,454
44,122
26,504
10,751
Net Income from Continuing & Discontinued Operation
-48,287
-48,287
-46,032
-27,472
-10,770
Normalized Income
-33,141
-33,141
-39,594
-26,464
-10,750
Interest Income
866
866
-
48.196
15.985
Interest Expense
-
-
-1,062
8.208
14.976
Net Interest Income
866
866
1,062
39.988
1.009
EBIT
-33,313
-33,313
-46,424
-27,463
-10,755
EBITDA
-30,082
-
-
-
-
Reconciled Cost of Revenue
9,508
9,508
3,935
-
-
Reconciled Depreciation
3,231
3,231
2,153
1,671
117.779
Net Income from Continuing Operation Net Minority Interest
-48,287
-48,287
-46,032
-27,472
-10,770
Total Unusual Items Excluding Goodwill
-15,146
-15,146
-6,438
-1,007
-19.891
Total Unusual Items
-15,146
-15,146
-6,438
-1,007
-19.891
Normalized EBITDA
-14,936
-14,936
-37,833
-24,785
-10,618
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0